Evolving Chemotherapy Options for the Treatment of Myeloma Kidney: A 40-Year Perspective
Authors:
- Esftathios KastritisEKEsftathios Kastritis
- Meletios A. DimopoulosMeletios A. Dimopoulos
- Joan BladéJBJoan Bladé
- 1 September 2012
- journal article
- review article
- Published by Elsevier in Advances in Chronic Kidney Disease
- Vol. 19 (5) , 312-323
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients’ renal functionAnnals of Oncology, 2011
- Renal Insufficiency and FailureHematology-American Society Hematology Education Program, 2010
- Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working GroupJournal of Clinical Oncology, 2010
- Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002—Medical Research Council Adult Leukaemia Working PartyJournal of Clinical Oncology, 2005
- Review of 1027 Patients With Newly Diagnosed Multiple MyelomaMayo Clinic Proceedings, 2003
- Renal Failure in Multiple MyelomaArchives of internal medicine (1960), 1998
- Renal function in newly diagnosed multiple myeloma — A demographic study of 1353 patientsEuropean Journal of Haematology, 1994
- Renal failure in multiple myeloma. Pathogenesis and prognostic implicationsArchives of internal medicine (1960), 1990
- Analysis and management of renal failure in fourth MRC myelomatosis trial. MRC working party on leukaemia in adults.BMJ, 1984
- Acute renal failure in patients with multiple myelomaThe American Journal of Medicine, 1984